UnitedHealth Faces Earnings Growth Amid Stalling Sales
UnitedHealth (UNH) reported strong earnings growth in Q2 2026, with operating profits rising by 55% and a raised full-year adjusted EPS guidance to $19.50–$20 per share. However, revenue has nearly stalled after growing over 12% for two quarters before slowing significantly. The company attributes the earnings rebound primarily to pricing strategies rather than sales growth. Despite flat revenue, UnitedHealth is relying on margin expansion and a shrinking share count to maintain its long-term EPS growth target of 13–16%. However, rising medical costs—particularly in commercial plans—are posing challenges. Medical cost trends remain high due to arbitration under the No Surprises Act, which adds about 50 basis points to trend rates. The company expects continued pressure on margins through at least 2027 and is watching closely for any moderation in these trends. Investors are advised to monitor upcoming Q3 results for updates on medical cost trends and Medicare estimates.
Tickers: $UNH
Topics: medical costs Medicare Advantage pricing strategy UNH stock UnitedHealth